COVID-19 has made consumers more conscious of symptoms such as throat itches, sore throats, and coughs, as well as colds, and encouraged them to take a more proactive approach to the treatment of such symptoms. Moreover, this strengthened consumers’ desire to stock up on medication for coughs and colds, especially under the strict lockdown conditions prevailing during the period from March to June.
While the overall cough, cold and allergy (hay fever) remedies category is relatively cushioned from the impact of COVID-19, it is expected to see a dip in growth in 2020 compared with the previous year. This is mainly due to home seclusion, which has meant that consumers have been less exposed to the viruses that cause coughs and colds than usual.
Procter & Gamble Hygiene & Health Care Ltd remains the largest player in cough, cold and allergy (hay fever) remedies thanks to the strength of its Vicks brand. As part of its COVID-19 response in India, the Vicks brand donated more than 33,000 protective hygiene and ration kits to the elderly in need.
While the COVID-19 pandemic has generated demand for fast relief from the symptoms of coughs, colds and allergies, the forecast period is set to see the revival of consumer interest in more natural and traditional products. The general rise in consumer health-consciousness continues to contribute to concerns about the potentially harmful effects of long-term regular ingestion of OTC medication, boosting demand for products that are perceived to be natural, gentler, and supported by long traditions of use.
India’s weather conditions and high levels of pollution are likely to contribute to strong demand for cough, cold and allergy (hay fever) remedies during the forecast period. Indeed, during periods of particularly bad pollution, chemists have been reported to have faced shortages of medicines such as anti-allergy drugs.
The expansion of online pharmacies was already contributing to the development of cough, cold and allergy (hay fever) remedies in India prior to the outbreak of COVID-19. The broader product variety, competitive pricing, and convenience associated with e-commerce appealed to many consumers, especially time-pressed young working consumers.
Files are delivered directly into your account soon after payment is received and any tax is certification is verified (where applicable).
Understand the latest market trends and future growth opportunities for the Cough, Cold and Allergy (Hay Fever) Remedies industry in India with research from Euromonitor International's team of in-country analysts – experts by industry and geographic specialisation.
Key trends are clearly and succinctly summarised alongside the most current research data available. Understand and assess competitive threats and plan corporate strategy with our qualitative analysis, insight and confident growth projections.
If you're in the Cough, Cold and Allergy (Hay Fever) Remedies industry in India, our research will help you to make informed, intelligent decisions; to recognise and profit from opportunity, or to offer resilience amidst market uncertainty.
This report originates from Passport, our Cough, Cold and Allergy (Hay Fever) Remedies research and analysis database.
If you purchase a report that is updated in the next 60 days, we will send you the new edition and data extract FREE! Home Page